v3.26.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of components of income before income taxes

The components of income before income taxes are as follows:

 

 

For the years ended December 31,

 

 

2023

 

 

2024

 

 

2025

 

 

US$

 

 

US$

 

 

US$

 

Chinese mainland

 

 

12,562,152

 

 

 

35,007,671

 

 

 

21,956,167

 

Non-Chinese mainland

 

 

33,431,585

 

 

 

46,755,978

 

 

 

185,486,319

 

Total income before income taxes

 

 

45,993,737

 

 

 

81,763,649

 

 

 

207,442,486

 

Schedule of current and deferred portions of income taxes allocated to continuing operations

The current and deferred portions of income tax expense allocated to continuing operations, were as follows:

 

For the years ended December 31,

 

 

2023

 

 

2024

 

 

2025

 

 

US$

 

 

US$

 

 

US$

 

Current tax (expense)

 

 

 

 

 

 

 

 

 

    Chinese mainland

 

 

 

 

 

 

 

 

(77

)

    Non-Chinese mainland

 

 

(9,779,815

)

 

 

(19,580,355

)

 

 

(37,631,835

)

Total current tax (expense)

 

 

(9,779,815

)

 

 

(19,580,355

)

 

 

(37,631,912

)

Deferred tax (expense) benefit

 

 

 

 

 

 

 

 

 

    Chinese mainland

 

 

548,704

 

 

 

(2,782,703

)

 

 

606,219

 

    Non-Chinese mainland

 

 

(3,755,199

)

 

 

1,953,337

 

 

 

1,064,828

 

Total deferred tax (expense) benefit

 

 

(3,206,495

)

 

 

(829,366

)

 

 

1,671,047

 

Total income tax (expense) benefit

 

 

 

 

 

 

 

 

 

    Chinese mainland

 

 

548,704

 

 

 

(2,782,703

)

 

 

606,142

 

    Non-Chinese mainland

 

 

(13,535,014

)

 

 

(17,627,018

)

 

 

(36,567,007

)

Total income tax (expense)

 

 

(12,986,310

)

 

 

(20,409,721

)

 

 

(35,960,865

)

Summary of income tax paid (net of refund received) in different jurisdictions

The amounts of income taxes paid (net of refunds received) in different jurisdictions are set forth below:

 

For the years ended December 31,

 

 

2023

 

 

2024

 

 

2025

 

 

US$

 

 

US$

 

 

US$

 

Chinese mainland

 

 

 

 

 

 

 

 

77

 

Non-Chinese mainland

 

 

13,324,309

 

 

 

11,288,825

 

 

 

26,068,302

 

United States - federal

 

 

3,610,000

 

 

 

5,200,440

 

 

 

14,400,000

 

United States - New Jersey

 

 

729,000

 

 

 

2,971,000

 

 

 

5,120,000

 

New Zealand

 

 

8,190,515

 

 

 

2,365,230

 

 

 

5,183,060

 

Other jurisdictions

 

 

794,794

 

 

 

752,155

 

 

 

1,365,242

 

Total income tax paid

 

 

13,324,309

 

 

 

11,288,825

 

 

 

26,068,379

 

Schedule of significant components of the Group's deferred tax assets

The significant components of the Group’s deferred tax assets and liabilities were as follows:

 

As of December 31,

 

 

2024

 

 

2025

 

 

US$

 

 

US$

 

Deferred tax assets

 

 

 

 

 

 

Net operating loss carryforwards

 

 

22,460,370

 

 

 

21,363,776

 

Share-based compensation

 

 

4,104,367

 

 

 

6,140,895

 

Lease liabilities

 

 

2,019,091

 

 

 

2,369,987

 

Withholding tax credit carryforwards

 

 

1,013,796

 

 

 

139,758

 

Advertising expense carryforwards

 

 

807,824

 

 

 

828,788

 

Accrued expenses

 

 

504,250

 

 

 

894,354

 

Financial instruments held, at fair value

 

 

546,762

 

 

 

572,453

 

Allowance for doubtful accounts

 

 

860,624

 

 

 

1,699,590

 

Long-term investments

 

 

228,010

 

 

 

234,009

 

Total deferred tax assets

 

 

32,545,094

 

 

 

34,243,610

 

Less: valuation allowance

 

 

21,923,356

 

 

 

21,316,154

 

Deferred tax assets, net of valuation allowance

 

 

10,621,738

 

 

 

12,927,456

 

 

 

 

 

 

 

 

Deferred tax liabilities

 

 

 

 

 

 

Intangible assets

 

 

1,788,555

 

 

 

1,535,965

 

Right-of-use assets

 

 

1,945,981

 

 

 

2,229,588

 

Financial instruments held, at fair value

 

 

382,728

 

 

 

451,332

 

Total deferred tax liabilities

 

 

4,117,264

 

 

 

4,216,885

 

 

 

 

 

 

 

 

Deferred tax assets, net

 

 

8,573,135

 

 

 

10,404,896

 

Deferred tax liabilities, net

 

 

2,068,661

 

 

 

1,694,325

 

Schedule of movement of the valuation allowance

The movement of the valuation allowance is as follows:

 

For the years ended December 31,

 

 

2023

 

 

2024

 

 

2025

 

 

US$

 

 

US$

 

 

US$

 

Balance at the beginning of the year

 

 

11,307,489

 

 

 

18,262,801

 

 

 

21,923,356

 

Additions of valuation allowance

 

 

7,372,595

 

 

 

6,576,529

 

 

 

2,883,176

 

Reversals of valuation allowance

 

 

(187,483

)

 

 

(2,599,680

)

 

 

(4,185,003

)

Foreign currency translation adjustment

 

 

(229,800

)

 

 

(316,294

)

 

 

694,625

 

Net change in the valuation allowance

 

 

6,955,312

 

 

 

3,660,555

 

 

 

(607,202

)

Balance at the end of the year

 

 

18,262,801

 

 

 

21,923,356

 

 

 

21,316,154

 

 

Schedule of expiration status of net operating loss carryforwards

The expiration status of net operating loss carryforwards as of December 31, 2025 is listed below.

Expiration year

 

US$

 

2026

 

 

6,083,279

 

2027

 

 

7,206,834

 

2028

 

 

6,015,368

 

2029

 

 

4,573,483

 

2030 through 2045

 

 

65,146,458

 

Indefinitely

 

 

40,715,871

 

Schedule of Reconciliations between the income tax expense computed by applying the PRC's statutory income tax rate to income before income taxes and the actual income tax expense

Reconciliations between the income tax expense computed by applying the Chinese mainland's 25% statutory income tax rate, the standard enterprise income tax rate in the jurisdiction of tax domicile of a significant portion of our business, to income before income taxes and the reported income tax expense were as follows:

 

For the years ended December 31,

 

 

2023

 

 

2024

 

 

US$

 

 

US$

 

Income before income taxes

 

 

45,993,737

 

 

 

81,763,649

 

Chinese mainland statutory income tax rate

 

25%

 

 

25%

 

Income tax at statutory income tax rate

 

 

(11,498,434

)

 

 

(20,440,912

)

Effect of income tax rate difference in other jurisdictions

 

 

23,195

 

 

 

2,527,278

 

Effect of preferential tax rates

 

 

1,306,561

 

 

 

3,226,674

 

Super deduction of research and development expense

 

 

5,509,308

 

 

 

5,544,966

 

Nondeductible expenses

 

 

(1,998,354

)

 

 

(10,651,228

)

Non-taxable income

 

 

194,107

 

 

 

1,758,388

 

Changes in valuation allowance

 

 

(7,185,112

)

 

 

(3,976,849

)

Excess tax benefits from share-based compensation

 

 

662,419

 

 

 

1,601,962

 

Income tax expense

 

 

(12,986,310

)

 

 

(20,409,721

)

 

 

 

For the year ended December 31,

 

 

2025

 

 

US$

 

 

%

Income tax expense at statutory income tax rate

 

 

(51,860,621

)

 

25%

Foreign tax effects

 

 

 

 

 

   Singapore

 

 

 

 

 

      Statutory income tax rate difference between Chinese mainland and Singapore

 

 

3,521,285

 

 

-1.7%

      Others

 

 

(54,706

)

 

0.0%

   New Zealand

 

 

 

 

 

      Statutory income tax rate difference between Chinese mainland and New Zealand

 

 

(935,185

)

 

0.5%

      Tax effect of bad debt write-off

 

 

3,150,262

 

 

-1.5%

      Others

 

 

531,223

 

 

-0.3%

   Hong Kong

 

 

 

 

 

      Statutory income tax rate difference between Chinese mainland and Hong Kong

 

 

3,605,777

 

 

-1.7%

      Others

 

 

1,149,846

 

 

-0.6%

  United States

 

 

 

 

 

      Statutory income tax rate difference between Chinese mainland and United States

 

 

2,740,834

 

 

-1.3%

      State and local income taxes, net of federal income tax effect

 

 

(4,111,251

)

 

2.0%

      Others

 

 

303,347

 

 

-0.1%

   Other foreign jurisdictions

 

 

(96,864

)

 

0.0%

Changes in valuation allowance

 

 

(365,581

)

 

0.2%

Non-deductible expenses

 

 

(1,658,817

)

 

0.8%

Other adjustments

 

 

 

 

 

   Effect of preferential tax rates

 

 

2,502,281

 

 

-1.2%

   Super deduction of research and development expenses

 

 

3,090,613

 

 

-1.5%

   Excess tax benefits from share-based compensation

 

 

2,526,692

 

 

-1.2%

Income tax expense

 

 

(35,960,865

)

 

17.3%